← Open Payments lookup

PETER MORRIS: Open Payments

NPI 1275085649 · LAWRENCEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,414 in 80 payments from 10 companies in 2025. Trend: 2023 $562 · 2024 $884 · 2025 $1,414

Food & beverage: $1,414
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc16$294
Otsuka America Pharmaceutical, Inc.13$230
Neurocrine BioSciences, Inc.12$213
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$180
E.R. Squibb & Sons, L.L.C.10$178
Alkermes, Inc.6$108
Teva Pharmaceuticals USA, Inc.6$101
Vanda Pharmaceuticals Inc.3$47
ABBVIE INC.3$43
Takeda Pharmaceuticals U.S.A., Inc.1$19

Products named: INVEGA SUSTENNA, INGREZZA, CAPLYTA, COBENFY, REXULTI, ARISTADA, ABILIFY MAINTENA, UZEDY.

Industry payments across NJ — which companies pay providers there.